Nasdaq Halts KaloBios Pharmaceuticals, Inc.


NEW YORK, Dec. 17, 2015 (GLOBE NEWSWIRE) — The Nasdaq Stock Market® (Nasdaq:NDAQ) announced that trading was halted today in KaloBios Pharmaceuticals, Inc. (Nasdaq:KBIO) at 06:48:07 Eastern Time for “additional information requested” from the company at a last price of $23.59.

Trading will remain halted until KaloBios Pharmaceuticals, Inc. has fully satisfied Nasdaq’s request for additional information.

For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotesSM on the Nasdaq® Web site.

Q2 Hedge Funds Portable Database Now LIVE!!! Letters, Conferences, Slides And More [UPDATED 7/13 14:48 EST]

Q2 Hedge Funds Resource PageSimply click the menu below to perform sorting functions. This page was just created on 7/1/2020 we will be updating it on a very frequent basis over the next three months (usually at LEAST daily), please come back or bookmark the page. As always we REALLY really appreciate legal letters and tips on hedge funds Read More


For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com.

 

NDAQO

 

 

CONTACT: Nasdaq Media Contact:
Peter Gau
+1.212.231.5475
[email protected]